Proton therapy and the European Particle Therapy Network: The past, present and future.
Cancer
EPTN
European research infrastructure
European research networks
Infrastructures de recherche européennes
Proton therapy
Protonthérapie
Réseaux de recherche clinique européens
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
15
05
2020
revised:
19
05
2020
accepted:
20
05
2020
pubmed:
6
8
2020
medline:
9
10
2020
entrez:
6
8
2020
Statut:
ppublish
Résumé
Proton therapy is delivered to selected cancer patients presenting with rare tumours, for which a dose escalation paradigm and/or a reduced dose-bath to the organs at risk is pursued. It is a costly treatment with an additional cost factor of 2-3 when compared to photon radiotherapy. Notwithstanding the 180'000 patients treated with protons, scars robust clinical evidence is available to justify the administration of this treatment modality. The European Particle Therapy Network (EPTN) was created in 2015 to answer the critical European needs for cooperation among protons and carbon ions centres in the framework of clinical research networks. EPTN with other European groups will launch a number of prospective clinical trials that could be practice changing if positive. Alternative way to generate clinical data could be provided by alternative methodologies, such as the Dutch model-based approach, or could be provided by European infrastructure projects.
Identifiants
pubmed: 32753239
pii: S1278-3218(20)30160-8
doi: 10.1016/j.canrad.2020.05.002
pmc: PMC7395642
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
687-690Informations de copyright
Copyright © 2020 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.